share_log

CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer

CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer

CHMP建议授予Elahere治疗卵巢癌、输卵管癌或原发性腹膜癌的成年人的市场授权。
Benzinga ·  09/20 07:12

CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer

CHMP建议授予Elahere治疗卵巢癌、输卵管癌或原发性腹膜癌的成年人的市场授权。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发